Literature DB >> 12754326

Diagnosis and treatment of inflammatory muscle diseases.

David Hilton-Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12754326      PMCID： PMC1765624          DOI： 10.1136/jnnp.74.suppl_2.ii25

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  Progress in inflammatory myopathies: good but not good enough.

Authors:  M C Dalakas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

2.  A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

Authors:  M C Dalakas; B Koffman; M Fujii; S Spector; K Sivakumar; E Cupler
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

Review 3.  Treatment of autoimmune inflammatory myopathies.

Authors:  F L Mastaglia
Journal:  Curr Opin Neurol       Date:  2000-10       Impact factor: 5.710

4.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

Authors:  K Nagaraju; N Raben; L Loeffler; T Parker; P J Rochon; E Lee; C Danning; R Wada; C Thompson; G Bahtiyar; J Craft; R Hooft Van Huijsduijnen; P Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 5.  Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.

Authors:  V Askanas; W K Engel
Journal:  J Neuropathol Exp Neurol       Date:  2001-01       Impact factor: 3.685

6.  Disease progression in sporadic inclusion body myositis: observations in 78 patients.

Authors:  A Peng; B M Koffman; J D Malley; M C Dalakas
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

7.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 8.  Inflammatory muscle diseases.

Authors:  D Hilton-Jones
Journal:  Curr Opin Neurol       Date:  2001-10       Impact factor: 5.710
  8 in total
  10 in total

Review 1.  Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases.

Authors:  Rowan S Hardy; Karim Raza; Mark S Cooper
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

Review 2.  Differential diagnosis of idiopathic inflammatory myopathies.

Authors:  Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

3.  Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases.

Authors:  K N Ramesha; Abraham Kuruvilla; P S Sarma; V V Radhakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

4.  A case of diabetic myonecrosis: A rare complication of a common disease.

Authors:  Rami Alkhoury
Journal:  SAGE Open Med Case Rep       Date:  2019-01-12

Review 5.  Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss.

Authors:  Justine M Webster; Chloe G Fenton; Ramon Langen; Rowan S Hardy
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 6.208

6.  The RoScan Thermal 3D Body Scanning System: Medical Applicability and Benefits for Unobtrusive Sensing and Objective Diagnosis.

Authors:  Adam Chromy; Ludek Zalud
Journal:  Sensors (Basel)       Date:  2020-11-20       Impact factor: 3.576

7.  11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation.

Authors:  Rowan S Hardy; Craig L Doig; Zahrah Hussain; Mary O'Leary; Stuart A Morgan; Mark J Pearson; Amy Naylor; Simon W Jones; Andrew Filer; Paul M Stewart; Christopher D Buckley; Gareth G Lavery; Mark S Cooper; Karim Raza
Journal:  J Pathol       Date:  2016-10-18       Impact factor: 7.996

8.  Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis.

Authors:  C G Fenton; J M Webster; C S Martin; S Fareed; C Wehmeyer; H Mackie; R Jones; A P Seabright; J W Lewis; Y C Lai; C S Goodyear; S W Jones; M S Cooper; G G Lavery; R Langen; K Raza; R S Hardy
Journal:  Arthritis Res Ther       Date:  2019-08-01       Impact factor: 5.156

9.  Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.

Authors:  Francis F Furia; Evance Godfrey; Naomi Mwamanenge; Peter Swai
Journal:  Pediatr Rheumatol Online J       Date:  2020-04-03       Impact factor: 3.054

10.  Reduced miR-146a Promotes REG3A Expression and Macrophage Migration in Polymyositis and Dermatomyositis.

Authors:  Tingwang Jiang; Yuanlan Huang; Haohao Liu; Qiangwei Xu; Yanping Gong; Yao Chen; Xiaowei Hu; Zhijun Han; Mingzhu Gao
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.